FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

The FDA granted supplemental approval for ADVAIR HFA (fluticasone propionate and salmeterol xinafoate) by GlaxoSmithKline LLC, updating the product's labeling a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Advair HFA (fluticasone propionate/salmeterol)

Snippet

SUPPL AP for ADVAIR HFA (FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE)